Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the
“Company”), a leading AI and technology-enabled healthcare company,
today announced the appointment of Carol Murdock as Chief
Commercial Officer. She will lead Business Development, Account
Management, Marketing and Corporate Communications, reporting to
Mr. Terren Peizer, Chairman and CEO.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20190409005399/en/
Carol Murdock, Appointed as Chief
Commercial Officer at Catasys, Inc. (Photo: Business Wire)
Ms. Murdock joins the Company with over 30 years of healthcare
experience in market strategy and business development where her
managed care, technology and engagement expertise has helped
customers lower cost and improve quality of care.
Most recently, she served as the Chief Marketing Officer of
Healogics, the nation’s largest operator of outpatient wound care
centers, where she launched a data science team responsible for
publishing outcomes from the world’s largest wound care database.
Ms. Murdock previously served as the Senior Vice President and
Market Leader of Lumeris, a population health management company
where she helped payers and providers launch their value-based care
strategies. Prior to Lumeris, Ms. Murdock served as the Chief
Marketing Officer for MEDHOST, a commercial software company with
applications including an electronic medical record and emergency
department information system. She also served as Senior Vice
President, Marketing and Communications at Healthways; at the time,
an industry leader and pioneer in disease management, and more
recently a population health and wellbeing company. At Healthways,
Ms. Murdock led the integration of wellness acquisitions,
successfully launched multiple new products, grew the company’s
business with Cigna by 100%, and repositioned Healthways for
accelerated revenue growth.
Management Comments
Mr. Terren Peizer, Chairman and CEO of Catasys, stated, “I am
pleased to welcome Carol in the newly created role of Chief
Commercial Officer. She will be pivotal in driving our continued
rapid growth and expansion, leveraging her more than 30 years of
diverse healthcare experience, particularly as we broaden our
healthcare platform longer term. Her deep understanding of the
healthcare payer landscape and the needs of their members will
enable us to help even more people who experience unaddressed
behavioral health conditions that worsen chronic medical disease.
We are proud of the strength of our OnTrak programs, and the
trajectory of our market penetration with our health plan partners.
Our commercial success has been accomplished with a very small,
highly capable team who have built strong partnerships without any
reliance on marketing or business development infrastructure. With
Carol now joining our management team, we are very excited to be
entering a new level of growth acceleration and market share
expansion.“
Ms. Murdock stated, “I’m excited to join Catasys at such an
inflection point in the Company’s history. We have a unique
opportunity to build on our success in delivering financial
outcomes to payers, while achieving our mission to help improve the
health and save the lives of as many people as possible.”
About Catasys, Inc.
Catasys, Inc. harnesses proprietary big data predictive
analytics, artificial intelligence and telehealth, combined with
human interaction, to deliver improved member health and validated
outcomes and cost savings to health plans. Our mission is to help
improve the health and save the lives of as many people as
possible.
Catasys' integrated, technology-enabled OnTrak
solution--contracted with a growing number of national and regional
health plans--is designed to treat members with behavioral
conditions that cause or exacerbate co-existing medical conditions
such as diabetes, hypertension, coronary artery disease, COPD, and
congestive heart failure, which result in high medical costs.
Catasys has a unique ability to engage these members, who do not
otherwise seek behavioral healthcare, leveraging proprietary
enrollment capabilities built on deep insights into the drivers of
care avoidance.
OnTrak integrates evidence-based psychosocial and medical
interventions delivered either in-person or via telehealth, along
with care coaching and in-market Community Care Coordinators. The
program is currently improving member health and, at the same time,
is demonstrating reduced medical utilization, driving a more than
50 percent reduction in total health insurers' costs for enrolled
members. OnTrak is available to members of several leading health
plans in California, Connecticut, Florida, Georgia, Illinois, Iowa,
Kansas, Kentucky, Louisiana, Massachusetts, Missouri, Nebraska, New
Jersey, North Carolina, Oklahoma, Pennsylvania, South Carolina,
Tennessee, Texas, Virginia, West Virginia and Wisconsin.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed
in this press release are forward-looking and made pursuant to the
Safe Harbor provisions of the Private Securities Litigation Reform
Act of 1995. These forward-looking statements reflect numerous
assumptions and involve a variety of risks and uncertainties, many
of which are beyond our control, which may cause actual results to
differ materially from stated expectations. These risk factors
include, among others, changes in regulations or issuance of new
regulations or interpretations, limited operating history, our
inability to execute our business plan, increase our revenue and
achieve profitability, lower than anticipated eligible members
under our contracts, our inability to recognize revenue, lack of
outcomes and statistically significant formal research studies,
difficulty enrolling new members and maintaining existing members
in our programs, the risk that treatment programs might not be
effective, difficulty in developing, exploiting and protecting
proprietary technologies, intense competition and substantial
regulation in the health care industry, the risks associated with
the adequacy of our existing cash resources and our ability to
continue as a going concern, our ability to raise additional
capital when needed and our liquidity. You are urged to consider
statements that include the words "may," "will," "would," "could,"
"should," "believes," "estimates," "projects," "potential,"
"expects," "plan," "anticipates," "intends," "continues,"
"forecast," "designed," "goal," or the negative of those words or
other comparable words to be uncertain and forward-looking. For a
further list and description of the risks and uncertainties we
face, please refer to our most recent Securities and Exchange
Commission filings which are available on its website at
http://www.sec.gov. Such forward-looking statements are current
only as of the date they are made, and we assume no obligation to
update any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190409005399/en/
Catasys, Inc.Ariel Davis, 310-444-4346
Catasys (NASDAQ:CATS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catasys (NASDAQ:CATS)
Historical Stock Chart
From Jul 2023 to Jul 2024